Medroxyprogesterone Acetate Tablets
» Medroxyprogesterone Acetate Tablets contain not less than 93.0 percent and not more than 107.0 percent of the labeled amount of medroxyprogesterone acetate (C24H34O4).
Packaging and storage— Preserve in well-closed containers.
USP Reference standards 11
USP Medroxyprogesterone Acetate RS Click to View Structure
Identification— Triturate a number of Tablets, equivalent to about 25 mg of medroxyprogesterone acetate, with 15 mL of chloroform, filter, evaporate the chloroform on a steam bath, and dry the residue at 105 for 3 hours: the residue so obtained responds to Identification test A under Medroxyprogesterone Acetate.
Dissolution 711
Medium: 0.5% sodium lauryl sulfate; 900 mL.
Apparatus 2: 50 rpm.
Time: 45 minutes.
Determine the amount of C24H34O4 dissolved by employing the following method.
Sodium lauryl sulfate stock solution— Transfer 180.0 g of sodium lauryl sulfate to a 2000-mL volumetric flask. Add 1500 mL of water, and stir until dissolved. [note—Several hours of stirring are required. ] Dilute with water to volume.
Standard stock solution— Dissolve about 70 mg of USP Medroxyprogesterone Acetate RS, accurately weighed, in 140 mL of Sodium lauryl sulfate stock solution, and dilute with water to 250 mL. [note—It may be necessary to sonicate the solution to bring the Reference Standard into solution prior to dilution with water. Prepare this Standard stock solution fresh daily. ]
Standard solution— Pipet a 20-mL aliquot of Standard stock solution into a 1 L volumetric flask. Add 40 mL of Sodium lauryl sulfate stock solution, and dilute with water to volume. This solution is stable for up to 7 days.
Test solution— Withdraw 15 mL of the solution under test, and filter, discarding the first 5 mL of the filtrate.
Mobile phase— Prepare a filtered and degassed solution of acetonitrile and water (60:40). Make adjustments if necessary (see System Suitability under Chromatography 621).
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 254-nm detector and a 4-mm × 8-cm column that contains packing L7. The flow rate is about 1.5 mL per minute. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the tailing factor for the analyte peak is not more than 1.2; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the percentage of C24H34O4 dissolved from the peak responses so obtained.
Tolerances— Not less than 50% (Q) of the labeled amount of C24H34O4 is dissolved in 45 minutes.
Uniformity of dosage units 905: meet the requirements.
Procedure for content uniformity— Dissolve an accurately weighed portion of USP Medroxyprogesterone Acetate RS in a mixture of alcohol and water (3:1) to obtain a solution having a known concentration of about 15 µg per mL. Transfer 1 Tablet to a volumetric flask, add a mixture of alcohol and water (3:1) to volume, and shake for about 15 minutes. Filter, and quantitatively dilute a portion of the filtrate as required to obtain a final solution containing about 15 µg per mL. Concomitantly determine the absorbances of this solution and the Standard solution in 1-cm cells at the wavelength of maximum absorbance at about 242 nm. Calculate the quantity, in mg, of C24H34O4 in the Tablet taken by the formula:
(T/D)C(AU / AS)
in which T is the labeled quantity, in mg, of medroxyprogesterone acetate in the Tablet; D is the concentration, in µg per mL, of medroxyprogesterone acetate in the solution from the Tablet; C is the concentration, in µg per mL; of USP Medroxyprogesterone Acetate RS in the Standard solution, and AU and AS are the absorbances of the solution from the Tablet and the Standard solution, respectively.
Assay—
Mobile phase, Standard preparation, and Chromatographic system— Prepare as directed in the Assay under Medroxyprogesterone Acetate.
Assay preparation— Weigh and finely powder not fewer than 20 Tablets. Weigh accurately a portion of the powder, equivalent to about 25 mg of medroxyprogesterone acetate, into a 50-mL glass centrifuge tube. Pipet 25 mL of acetonitrile into the tube, shake to wet the powder thoroughly, and sonicate for not less than 10 minutes, and centrifuge. Use the clear supernatant as the Assay preparation.
Procedure— Proceed as directed for Procedure in the Assay under Medroxyprogesterone Acetate. Calculate the quantity, in mg, of medroxyprogesterone acetate (C24H34O4) in the portion of Tablets taken by the formula:
25C(rU / rS)
in which C is the concentration, in mg per mL, of USP Medroxyprogesterone Acetate RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Mary S. Waddell
Scientific Liaison
1-301-816-8124
(SM42010) Monographs - Small Molecules 4
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison
1-301-816-8106
(GCDF2010) General Chapters - Dosage Forms
USP35–NF30 Page 3781
Pharmacopeial Forum: Volume No. 27(1) Page 1800